Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1990 Nov;212(5):592–596. doi: 10.1097/00000658-199011000-00005

Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer.

S Fujimoto 1, R D Shrestha 1, M Kokubun 1, K Kobayashi 1, S Kiuchi 1, C Konno 1, M Ohta 1, M Takahashi 1, Y Kitsukawa 1, M Mizutani 1, et al.
PMCID: PMC1358186  PMID: 2241314

Abstract

To evaluate the clinical efficacy of intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastric cancer, particularly with peritoneal seeding, we investigated the survival times of 59 patients who underwent distal subtotal gastrectomy, total gastrectomy, or total gastrectomy combined with concomitant resection of some of the remaining intra-abdominal organs. In all the 30 patients given IPHP, no cancer cells were present posthyperthermically in the lavage from the Douglas pouch. The 30 patients given IPHP lived longer than the 29 patients not given IPHP (p = 0.001), with a 1-year survival rate of 80.4% in the former group compared to 34.2% in the latter. With respect to a comparison of survival time of patients with peritoneal seeding, 7 patients not given IPHP had a 6-month survival rate of 57.1% and did not survive more than 9 months, whereas 20 patients given IPHP had 1- and 2-year survival rates of 78.7% and 45.0%, respectively; here the difference was significant (p = 0.001). The IPHP and control groups without peritoneal metastasis included 10 and 22 patients, respectively, and the 1-year survival rates are 85.4% and 45.3%, respectively. The survival rates of the former exceeded those of the latter, with p = 0.015 by the generalized Wilcoxon test. Thus this combined therapy offers the promise of extended survival for patients with far-advanced gastric cancer.

Full text

PDF
595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang A. E., Schneider P. D., Sugarbaker P. H., Simpson C., Culnane M., Steinberg S. M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987 Dec;206(6):685–693. doi: 10.1097/00000658-198712000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dewey W. C. Interaction of heat with radiation and chemotherapy. Cancer Res. 1984 Oct;44(10 Suppl):4714s–4720s. [PubMed] [Google Scholar]
  3. Fujimoto S., Shrestha R. D., Kokubun M., Kobayashi K., Kiuchi S., Takahashi M., Konno C., Ohta M., Koike S., Kitsukawa Y. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer. 1989 Jul 1;64(1):154–160. doi: 10.1002/1097-0142(19890701)64:1<154::aid-cncr2820640126>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  4. Fujimoto S., Shrestha R. D., Kokubun M., Ohta M., Takahashi M., Kobayashi K., Kiuchi S., Okui K., Miyoshi T., Arimizu N. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg. 1988 Jul;208(1):36–41. doi: 10.1097/00000658-198807000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  6. Koga S., Hamazoe R., Maeta M., Shimizu N., Murakami A., Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988 Jan 15;61(2):232–237. doi: 10.1002/1097-0142(19880115)61:2<232::aid-cncr2820610205>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  7. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Spratt J. S., Adcock R. A., Muskovin M., Sherrill W., McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980 Feb;40(2):256–260. [PubMed] [Google Scholar]
  9. Yamada S., Takeda T., Matsumoto K. Prognostic analysis of malignant pleural and peritoneal effusions. Cancer. 1983 Jan 1;51(1):136–140. doi: 10.1002/1097-0142(19830101)51:1<136::aid-cncr2820510127>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES